Takeda Pharmaceutical Newsroom

Oppenheimer Cuts Ovid to Perform, Cites Uncertainty Over Lead Drug

Seeking AlphaJun 18 12:29 ET

Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy

MT NewswiresFeb 13 03:41 ET

Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy

MT NewswiresOct 3, 2023 05:49 ET

Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy

MT NewswiresSep 22, 2023 07:30 ET

TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating

MT NewswiresMay 16, 2023 09:16 ET

TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating

MT NewswiresApr 4, 2023 08:27 ET

Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy

MT NewswiresMar 6, 2023 05:14 ET

Takeda upgraded to outperform at Cowen on valuation, cash flow

Seeking AlphaJul 19, 2022 13:31 ET

Cowen & Co. Upgrades Takeda Pharmaceutical to Outperform, Raises Price Target to $24

Benzinga Real-time NewsJul 19, 2022 07:54 ET

Takeda Pharmaceutical analyst ratings

Benzinga Analyst RatingsJul 19, 2022 07:50 ET